Package 71335-0141-1

{"route": ["ORAL"], "spl_id": "39e1f055-07cb-4322-a186-94249784cfdd", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95", "4B9XT59T7S"], "rxcui": ["200082"], "spl_set_id": ["1add9fef-69e4-4f74-a17c-99d59de28441"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "6 TABLET in 1 BOTTLE (71335-0141-1)", "package_ndc": "71335-0141-1", "marketing_start_date": "20161210"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-0141-2)", "package_ndc": "71335-0141-2", "marketing_start_date": "20161210"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE (71335-0141-3)", "package_ndc": "71335-0141-3", "marketing_start_date": "20161210"}], "brand_name": "Lamivudine and Zidovudine", "product_id": "71335-0141_39e1f055-07cb-4322-a186-94249784cfdd", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "71335-0141", "generic_name": "Lamivudine and Zidovudine", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine and Zidovudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}, {"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA079128", "marketing_category": "ANDA", "marketing_start_date": "20161210", "listing_expiration_date": "20261231"}